1 December 2023
Ropes & Gray Represents ImmunoGen in its $10.1 Billion Sale to AbbVie
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Tara Fisher Lead | Ropes & Gray | Partner | mergers & acquisitions | Not stated |
| Renata Ferrari Lead | Ropes & Gray | Partner | executive compensation & employee benefits | Not stated |
| Mike McFalls Lead | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Ruchit Patel Lead | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| David McIntosh Lead | Ropes & Gray | Partner | IP transactions | Not stated |
| Dan Coyne Lead | Ropes & Gray | Partner | finance | Not stated |
| David Saltzman Lead | Ropes & Gray | Partner | tax | Not stated |
| Tyler Silvey | Ropes & Gray | Associate | corporate | Not stated |
Stated terms
- Stated value
- USD 10.1bn ($10.1 billion)
- What the figure measures
- Total transaction value
- Client
- ImmunoGenSell-side
- Counterparties
- AbbVie (Buy-side)